- Home
- SIEB vs SGMO Comparison
SIEB vs SGMO Comparison
Compare SIEB & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SIEB | SGMO |
|---|---|---|
| Founded | 1886 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.1M | 141.2M |
| IPO Year | 1996 | 2000 |
Fundamental Metrics
Financial Performance| Metric | SIEB | SGMO |
|---|---|---|
| Price | $1.85 | $0.41 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.75 |
| AVG Volume (30 Days) | 37.2K | ★ 4.1M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 57.14 | ★ 66.89 |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $83,901,000.00 | $36,567,000.00 |
| Revenue This Year | N/A | $4.79 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.29 | ★ N/A |
| Revenue Growth | 17.32 | ★ 88.60 |
| 52 Week Low | $1.82 | $0.35 |
| 52 Week High | $5.53 | $1.05 |
Technical Indicators
Market Signals| Indicator | SIEB | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 15.73 | 50.19 |
| Support Level | N/A | $0.36 |
| Resistance Level | $3.26 | $0.56 |
| Average True Range (ATR) | 0.12 | 0.04 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 9.38 | 28.31 |
Price Performance
Historical ComparisonAbout SIEB Siebert Financial Corp.
Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.